Masocol, Kate Ayiesshajoy P.
HRN: 20-55-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/08/2025
01/14/2025
OD
5ml
Q8
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes